|
🐜
|
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
42 auth.
F. van Rhee,
P. Voorhees,
A. Dispenzieri,
A. Fosså,
G. Srkalović,
M. Ide,
N. Munshi,
S. Schey,
M. Streetly,
S. Pierson,
H. Partridge,
S. Mukherjee,
D. Shilling,
K. Stone,
Amy D Greenway,
...
J. Ruth,
M. Lechowicz,
S. Chandrakasan,
Raj K. Jayanthan,
E. Jaffe,
H. Leitch,
N. Pemmaraju,
A. Chadburn,
M. Lim,
K. Elenitoba-Johnson,
V. Krymskaya,
A. Goodman,
C. Hoffmann,
P. Zinzani,
S. Ferrero,
L. Terriou,
Y. Sato,
D. Simpson,
R. Wong,
J. Rossi,
S. Nasta,
K. Yoshizaki,
R. Kurzrock,
T. Uldrick,
C. Casper,
É. Oksenhendler,
D. Fajgenbaum
|
8 |
2018 |
8
🐜
|
|
🐜
|
Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis.
10 auth.
J. Mangel,
H. Leitch,
J. Connors,
R. Buckstein,
K. Imrie,
D. Spaner,
...
M. Crump,
N. Pennell,
A. Boudreau,
N. Berinstein
|
6 |
2004 |
6
🐜
|
|
🦁
|
Limited-stage mantle-cell lymphoma.
H. Leitch,
R. Gascoyne,
M. Chhanabhai,
N. Voss,
R. Klasa,
J. Connors
|
6 |
2003 |
6
🦁
|
|
🐜
|
Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study
21 auth.
R. Buckstein,
R. Wells,
N. Zhu,
H. Leitch,
T. Nevill,
K. Yee,
B. Leber,
M. Sabloff,
Eve St Hilaire,
Rajat Kumar,
...
M. Geddes,
A. Shamy,
J. Storring,
A. Kew,
M. Elemary,
M. Levitt,
M. Lenis,
A. Mamedov,
Liying Zhang,
K. Rockwood,
S. Alibhai
|
6 |
2016 |
6
🐜
|
|
🦁
|
Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy.
H. Leitch
|
6 |
2007 |
6
🦁
|
|
🦁
|
Improved Survival in Patients with Myelodysplastic Syndrome Receiving Iron Chelation Therapy
10 auth.
H. Leitch,
C. Léger,
Trisha A. Goodman,
K. Wong,
Dominica H. C. Wong,
K. Ramadan,
...
M. Rollins,
M. Barnett,
P. Galbraith,
L. Vickars
|
6 |
2008 |
6
🦁
|
|
🐜
|
Design of long circulating nontoxic dendritic polymers for the removal of iron in vivo.
8 auth.
Muhammad Imran ul-haq,
J. L. Hamilton,
B. Lai,
R. A. Shenoi,
Sonja A Horte,
I. Constantinescu,
...
H. Leitch,
J. Kizhakkedathu
|
6 |
2013 |
6
🐜
|
|
🐜
|
Aplastic anemia following administration of a tumor necrosis factor‐α inhibitor
7 auth.
J. Kuruvilla,
H. Leitch,
L. Vickars,
P. Galbraith,
Charles H. Li,
Saad Al-Saab,
...
S. Naiman
|
5 |
2003 |
5
🐜
|
|
🐢
|
Improved Outcome of Human Immunodeficiency Virus-Associated Plasmablastic Lymphoma of the Oral Cavity in the Era of Highly Active Antiretroviral Therapy: A Report of Two Cases
8 auth.
Richard T. Lester,
Charles H. Li,
P. Phillips,
T. Shenkier,
R. Gascoyne,
P. Galbraith,
...
L. Vickars,
H. Leitch
|
5 |
2004 |
5
🐢
|
|
🦁
|
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an MDS‐CAN analysis
24 auth.
H. Leitch,
Ambica Parmar,
R. Wells,
L. Chodirker,
N. Zhu,
T. Nevill,
K. Yee,
B. Leber,
M. Keating,
M. Sabloff,
...
Eve St Hilaire,
Rajat Kumar,
R. Delage,
M. Geddes,
J. Storring,
A. Kew,
A. Shamy,
M. Elemary,
M. Lenis,
A. Mamedov,
J. Ivo,
J. Francis,
Liying Zhang,
R. Buckstein
|
5 |
2017 |
5
🦁
|
